Netscientific Share Discussion Threads

[cinques] 29/5/2015 00:25

yeah ... remember to watch the liquidity, both up and down!

[cinques] 29/5/2015 00:00

Phase 1 ... it's early days for the drug trials.

However, tomorrow will see more interest.

[cinques] 28/5/2015 23:38

Hyper Al,

The stake that NSCI has in PDS is 14.85% of PDS's share capital. NSCI also have warrants to buy more PDS shares. The warrants were valued at £100k in the EoY NSCI accounts. I have no idea what warrants there are, but let's say that, including the warrants, NSCI own 20% of PDS.

See page 37 of the 2014 annual report - link on this page:



NSCI have just under 36,000,000 shares in issue. The share price jumped 67.5p today, or about £24m added to the NSCI MCap.

This implies about £120m was added to PDS's value.

If PDS really has a cure for HPV induced cancers, £120m is peanuts.

However, this is just a Phase 1 trial and there are more steps to go.

I can see a higher price tomorrow. I don't own any of these, but I'll be buying some in the morning.

[cottoner] 28/5/2015 23:18

The amount of the investment by NSCI in PDS appears to have been undisclosed.

[bckttsim] 28/5/2015 22:28

From PDS site.Fourth Quarter 2014PDS continues to make excellent progress with its ongoing phase 1 human clinical trial for PDS0101. Testing of the product in the final and highest dose cohort is in progress.PDS received its first institutional investment from NetScientific (AIM: NSCI), the biomedical and healthcare technology group in December 2014.In addition, Sir Richard Sykes accepted an invitation to join PDS's board as Executive Chairman. Sir Richard was CEO and Chairman of GlaxoWellcome, and also Chairman of GSK. The following individuals also joined the board: Mr. De Lyle Bloomquist, President, Global Chemicals Business for Tata Chemicals Ltd. and President, CEO and Director of Tata Chemicals North America Inc.; Michael Boyce-Jacino, PhD, Executive Director of NetScientific and CEO of QLIDA; and Mr. Greg Freitag, General Counsel, Senior Vice President of Business Development, Ex-CFO and current Director of AxoGen, Inc.

[luminoso] 28/5/2015 22:01

Hi Hyper. Good Luck searching! Not sure why its not stated in the RNS.

[bad robot] 28/5/2015 21:48

BOOOM BOOOOM

Tomorrow morning.

FIRE AT WILL FROM 8.00 A.M

I HAVE ALWAYS BEEN KEEN ON SMALL PHARMA'S

CHECK OUT GWP. I AM 12 BAGGER UP IN 2 YEARS.

[luminoso] 28/5/2015 21:37

Still no indication anywhere as to how much of PDS Netscientific own - as cottoner has pointed out.

[65jack] 28/5/2015 21:15

i would not be surprised to see another 100% tomm at all

[65jack] 28/5/2015 21:10

tks mira interesting

[mirabeau] 28/5/2015 20:49

Sir Richard Sykes became a PSD board member last year. I think he was the ex-CEO of GSK. He's a big bloody hitter in the pharma sphere. A huge vote of confidence in PSD it seems

[65jack] 28/5/2015 20:42

Today 19:44NotaSpuddingClueRNS191.50No Opinion

I don't post much but has anyone read that RNS properly ?! When people read it thoroughly and truly understand what impact this could have I honestly believe a few quid share price will be a distant memory ! See you all next year and good luck ;)

[mirabeau] 28/5/2015 20:09

Looking very promising now though extremely illiquid but that's a huge bonus on a good news day like today

I wonder if Woodford is adding?

[goodbloke1] 28/5/2015 19:39

I always like to acknowledge research by other people.